Baricitinib: JAK inhibition for rheumatoid arthritis.
J. Gras
págs. 543-550
Daratumumab: monoclonal antibody therapy to treat multiple myeloma.
C. Xia, A. A. C. M. Ribeiro, E.S. Scott, S.C. Lonial
págs. 551-560
Osimertinib, a third-generation tyrosine kinase inhibitor targeting non-small cell lung cancer with EGFR T790M mutations.
C.E McCoach, Antonio Jimeno
págs. 560-568
Notable deals in the pharmaceutical industry in the third quarter of 2016.
Elisabet Cruces
págs. 569-576
Stem Cell and Regenerative Medicine Global Conference (SCRGC) 2016 (August 23-24, 2016 – Gyeonggi-do, Korea).
A. Vértes
págs. 577-584
New products intros
pág. 585
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: